Crossing the valley of death with advanced cancer therapy
Kategorier: Andra medicinska specialiteter Behandling och behandlingsmetoder Genterapi Klinisk medicin och internmedicin Medicin och omvårdnad Onkologi Sjukdomar och rubbningar
Experimental therapies can strike controversy, but they are becoming increasingly common as the gap between routine treatments and clinical trials becomes wider. Progress in science has identified an increasing number of interventions that might be useful for patients suffering from currently incurable cancer, neurological and metabolic diseases or infections such as Ebola. In his book Dr Hemminki explains the differences between treatments and trials, and why both are necessary to optimally harness progress in science into benefits for patients.
Akseli Hemminki, MD, PhD, has more than 2 decades of experience in translational cancer research and is now a professor of oncology at the University of Helsinki in Finland and father of 3 children. He has authored more than 200 scientific papers, founded 2 biotechnology companies and been involved in a dozen clinical trials.
"On a journey to make the world a better place, Dr Hemminki discovers he has to fight more than just disease. He also comes to understand it is not just the patients that have to make sacrifices in the fight to advance medical knowledge."